Hypercapnia is clinically defined as an arterial blood partial pressure of CO2 of above 40 mmHg and is a feature of chronic
lung disease. In previous studies we have demonstrated that
hypercapnia modulates agonist-stimulated cAMP levels through effects on transmembrane
adenylyl cyclase activity. In the airways, cAMP is known to regulate
cystic fibrosis transmembrane conductance regulator (CFTR)-mediated
anion and fluid secretion, which contributes to airway surface liquid homeostasis. The aim of the current work was to investigate if
hypercapnia could modulate cAMP-regulated ion and fluid transport in human airway epithelial cells. We found that acute exposure to
hypercapnia significantly reduced
forskolin-stimulated elevations in intracellular cAMP as well as both
adenosine- and
forskolin-stimulated increases in CFTR-dependent transepithelial short-circuit current, in polarised cultures of Calu-3 human airway cells. This CO2 -induced reduction in
anion secretion was not due to a decrease in HCO3 (-) transport given that neither a change in CFTR-dependent HCO3 (-) efflux nor Na(+) /HCO3 (-) cotransporter-dependent HCO3 (-) influx were CO2 -sensitive.
Hypercapnia also reduced the volume of
forskolin-stimulated fluid secretion over 24 h, yet had no effect on the HCO3 (-) content of the secreted fluid. Our data reveal that
hypercapnia reduces CFTR-dependent, electrogenic Cl(-) and fluid secretion, but not CFTR-dependent HCO3 (-) secretion, which highlights a differential sensitivity of Cl(-) and HCO3 (-) transporters to raised CO2 in Calu-3 cells.
Hypercapnia also reduced
forskolin-stimulated CFTR-dependent
anion secretion in primary human airway epithelia. Based on current models of airways biology, a reduction in fluid secretion, associated with
hypercapnia, would be predicted to have important consequences for airways hydration and the innate defence mechanisms of the lungs.